Prioritising AIDS/advanced HIV disease and TB treatment in Unitaid’s Investment Plan and Strategic Framework for 2022-2026.

Trend expected to continue without urgent investments in TB services to recover from impact of COVID-19.

Treatment Action Group (TAG) launches newly available TB chapters of its 2021 Pipeline Report.

Stop TB Partnership highlights devastating and continued impact of COVID-19 pandemic on children affected by TB.

Treatment Action Group releases a patent landscape investigating potential patent barriers for the development and delivery of long-acting formulations for selected hepatitis C and TB medicines.

The TB Europe Coalition releases a new guide for affected community, civil society organizations, National TB Programs and policy makers in Eastern Europe and Central Asia.

The TB Europe Coalition releases a new document, aiming to assist TB civil society organizations and community organizations from EECA countries in influencing national monitoring, data collection and accountability systems.

The World Health Organization issues a new compendium of data and evidence-related tools for use in TB planning and programming.

This new resource provides activists with information about two shorter treatment regimens for drug-sensitive TB, and equips them with actions they can take and arguments they can use to advocate for access to those regimens.

A newly released policy brief is meant to help better understand the UN Common Position on Ending HIV, TB and Viral Hepatitis through Intersectoral Collaboration, and to present the best practices of civil society for integrated response on TB, HIV and viral hepatitis.